These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 1372810

  • 1. The role of insulin-sensitive phosphodiesterase in insulin action.
    Makino H, Suzuki T, Kajinuma H, Yamazaki M, Ito H, Yoshida S.
    Adv Second Messenger Phosphoprotein Res; 1992; 25():185-99. PubMed ID: 1372810
    [Abstract] [Full Text] [Related]

  • 2. Role of adenosine 3',5'-monophosphate and the Ri-receptor Gi-coupled adenylate cyclase inhibitory pathway in the mechanism whereby adrenalectomy increases the adenosine antilipolytic effect in rat fat cells.
    de Mazancourt P, Lacasa D, Giot J, Giudicelli Y.
    Endocrinology; 1989 Mar; 124(3):1131-9. PubMed ID: 2465135
    [Abstract] [Full Text] [Related]

  • 3. Effects of the new phosphodiesterase inhibitor griseolic acid on insulin release in rat pancreatic islets.
    Hashimoto N, Makino H, Kanatsuka A, Yamazaki M, Yoshida S.
    Arzneimittelforschung; 1990 Oct; 40(10):1098-101. PubMed ID: 1705426
    [Abstract] [Full Text] [Related]

  • 4. Selective effects of phosphodiesterase inhibitors on different phosphodiesterases, adenosine 3',5'-monophosphate metabolism, and lipolysis in 3T3-L1 adipocytes.
    Elks ML, Manganiello VC.
    Endocrinology; 1984 Oct; 115(4):1262-8. PubMed ID: 6207009
    [Abstract] [Full Text] [Related]

  • 5. Differential effects of two phosphodiesterase inhibitors on fat cell metabolism.
    Shechter Y.
    Endocrinology; 1984 Nov; 115(5):1787-91. PubMed ID: 6208014
    [Abstract] [Full Text] [Related]

  • 6. Cellular tolerance to adenosine receptor-mediated inhibition of lipolysis: altered adenosine 3',5'-monophosphate metabolism and protein kinase activation.
    Hoffman BB, Prokocimer P, Thomas JM, Vagelos R, Chang H, Reaven GM.
    Endocrinology; 1989 May; 124(5):2434-42. PubMed ID: 2539980
    [Abstract] [Full Text] [Related]

  • 7. Maintenance of meiotic arrest in mouse oocytes by purines: modulation of cAMP levels and cAMP phosphodiesterase activity.
    Downs SM, Daniel SA, Bornslaeger EA, Hoppe PC, Eppig JJ.
    Gamete Res; 1989 Jul; 23(3):323-34. PubMed ID: 2476369
    [Abstract] [Full Text] [Related]

  • 8. Effect of N6-(L-2-phenylisopropyl)adenosine and insulin on cAMP metabolism in 3T3-L1 adipocytes.
    Elks ML, Jackson M, Manganiello VC, Vaughan M.
    Am J Physiol; 1987 Mar; 252(3 Pt 1):C342-8. PubMed ID: 3030132
    [Abstract] [Full Text] [Related]

  • 9. The antilipolytic effect of insulin in human adipocytes requires activation of the phosphodiesterase.
    Lönnroth P, Smith U.
    Biochem Biophys Res Commun; 1986 Dec 30; 141(3):1157-61. PubMed ID: 2434081
    [Abstract] [Full Text] [Related]

  • 10. Insulin stimulation of cyclic AMP phosphodiesterase is independent from the G-protein pathways involved in adenylate cyclase regulation.
    Weber HW, Chung FZ, Day K, Appleman MM.
    J Cyclic Nucleotide Protein Phosphor Res; 1986 Dec 30; 11(5):345-54. PubMed ID: 3040818
    [Abstract] [Full Text] [Related]

  • 11. Role of hormone-sensitive low Km cAMP phosphodiesterase in regulation of cAMP-dependent protein kinase and lipolysis in rat adipocytes.
    Smith CJ, Manganiello VC.
    Mol Pharmacol; 1989 Mar 30; 35(3):381-6. PubMed ID: 2538713
    [Abstract] [Full Text] [Related]

  • 12. Human fat cell lipolysis is primarily regulated by inhibitory modulators acting through distinct mechanisms.
    Kather H, Bieger W, Michel G, Aktories K, Jakobs KH.
    J Clin Invest; 1985 Oct 30; 76(4):1559-65. PubMed ID: 2997284
    [Abstract] [Full Text] [Related]

  • 13. Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis.
    Torphy TJ, Zhou HL, Burman M, Huang LB.
    Mol Pharmacol; 1991 Mar 30; 39(3):376-84. PubMed ID: 1848659
    [Abstract] [Full Text] [Related]

  • 14. Quantitative differences in the cyclic AMP-lipolysis relationships for isoproterenol and forskolin.
    Allen DO, Quesenberry JT.
    J Pharmacol Exp Ther; 1988 Mar 30; 244(3):852-8. PubMed ID: 2855246
    [Abstract] [Full Text] [Related]

  • 15. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P, Prigent AF, Lagarde M, Nemoz G.
    Mol Pharmacol; 1993 Nov 30; 44(5):1027-35. PubMed ID: 8246905
    [Abstract] [Full Text] [Related]

  • 16. N6-(Phenylisopropyl)adenosine prevents glucagon both blocking insulin's activation of the plasma-membrane cyclic AMP phosphodiesterase and uncoupling hormonal stimulation of adenylate cyclase activity in hepatocytes.
    Wallace AV, Heyworth CM, Houslay MD.
    Biochem J; 1984 Aug 15; 222(1):177-82. PubMed ID: 6089755
    [Abstract] [Full Text] [Related]

  • 17. A role for soluble cAMP phosphodiesterases in differentiation of 3T3-L1 adipocytes.
    Elks ML, Manganiello VC.
    J Cell Physiol; 1985 Aug 15; 124(2):191-8. PubMed ID: 2413050
    [Abstract] [Full Text] [Related]

  • 18. Antilipolytic action of insulin: role of cAMP phosphodiesterase activation.
    Elks ML, Manganiello VC.
    Endocrinology; 1985 May 15; 116(5):2119-21. PubMed ID: 2985373
    [Abstract] [Full Text] [Related]

  • 19. Mechanism of lipolytic action of a new alpha-2 adrenergic antagonist of the piperazinopyrimidine family: RP 55462.
    Saulnier-Blache JS, Taouis M, Dauzats M, Uzan A, Berlan M, Lafontan M.
    J Pharmacol Exp Ther; 1989 Dec 15; 251(3):1193-8. PubMed ID: 2481031
    [Abstract] [Full Text] [Related]

  • 20. Mechanism of intracellular calcium ([Ca2+]i) inhibition of lipolysis in human adipocytes.
    Xue B, Greenberg AG, Kraemer FB, Zemel MB.
    FASEB J; 2001 Nov 15; 15(13):2527-9. PubMed ID: 11641262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.